Zobrazeno 1 - 10
of 50
pro vyhledávání: '"K. V. Voronkova"'
Autor:
A. M. Alieva, V. A. Kislyakov, K. V. Voronkova, E. V. Reznik, R. A. Arakelyan, M. N. Saryev, R. K. Valiev, A. M. Rakhaev, E. T. Hasanova, M. R. Kalova, I. G. Nikitin
Publikováno v:
Архивъ внутренней медицины, Vol 12, Iss 6, Pp 422-429 (2022)
Inflammation is a universal response of a living organism to various damaging factors and is aimed at restoring tissue integrity and minimizing cell death. Proinflammatory cytokines, in particular interleukins, are active participants in the inflamma
Externí odkaz:
https://doaj.org/article/3410649714104f608c6405433ac82947
Autor:
A. M. Alieva, I. E. Baykova, K. V. Voronkova, N. V. Teplova, L. M. Shnakhova, R. K. Valiev, D. A. Elmurzaeva, A. M. Rakhaev, M. R. Kalova, I. G. Nikitin
Publikováno v:
Klinicist, Vol 16, Iss 1, Pp 12-20 (2022)
Introduction. Currently, the search and study of new biological markers that can help early diagnosis of heart failure, serve as a laboratory tool for assessing the effectiveness of therapy, be a predictive marker of possible adverse clinical outcome
Externí odkaz:
https://doaj.org/article/0624d936bda3466295cf52809be9884c
Publikováno v:
Klinicist, Vol 15, Iss 1-4, Pp 42-46 (2022)
Heart failure (HF) remains a serious problem in Russian and world health care due to the growing morbidity and mortality from complications of heart failure, despite the development and implementation of programs for the early detection and treatment
Externí odkaz:
https://doaj.org/article/aa2234838ffe425c9722536908d15778
Autor:
K. V. Voronkova, M. N. Klochkov, N. Yu. Koroleva, S. S. Ivanov, A. B. Dmitriev, E. S. Bolshakova, E. F. Fatykhova, A. A. Usoltseva, D. V. Dmitrenko, A. A. Feygina, Ya. N. Koshelyaevskaya
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 13, Iss 2, Pp 106-122 (2021)
Objective: to assess efficacy and safety of vagus nerve stimulation (VNS) in patients with pharmacoresistant epilepsy.Material and methods. A multi-center retrospective observational program was applied in patients with pharmacoresistant epilepsy by
Externí odkaz:
https://doaj.org/article/d37245fb75c840c987bd927499599824
Autor:
R. Kh. Lyukmanov, A. A. Rimkevichus, E. V. Shalimanova, K. V. Voronkova, N. A. Suponeva, М. А. Piradov
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 13, Iss 1, Pp 51-64 (2021)
Patients with epilepsy may require a neurorehabilitation aid particularly due to developing motor alterations related to stroke, sequelae of traumatic brain injury, multiple sclerosis and other brain damage. Modern neurorehabilitation approaches dire
Externí odkaz:
https://doaj.org/article/cd64fe43280e4efab6346fbe8537dcfc
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 11, Iss 3, Pp 286-292 (2019)
The existing approaches to treating epilepsy can be classified as therapeutic and/or surgical. In most cases, a patient with epilepsy is examined by a neurologist (or psychiatrist) and receives antiepileptic drugs (AEDs) in order to control seizures.
Externí odkaz:
https://doaj.org/article/85cab61253b64be2a8c2fb3dc3c8175b
Autor:
G. N. Avakyan, D. V. Blinov, G. G. Avakyan, E. S. Akarachkova, S. G. Burd, P. N. Vlasov, K. V. Voronkova, V. I. Guzeva, I. A. Zhidkova, E. A. Katunina, D. I. Korabelnikov, A. V. Lebedeva, L. V. Lipatova, E. A. Morozova, O. M. Oleinikova, I. G. Rudakova
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 11, Iss 2, Pp 110-123 (2019)
For more than half a century, valproic acid (VA) has been a first-line drug to control seizures in various forms of epilepsy and status epilepticus; VA is also used in bipolar disorders. However, the accumulated clinical evidence indicates negative o
Externí odkaz:
https://doaj.org/article/41a8613ac2b247429b6174d42260553d
Autor:
K. V. Voronkova, A. E. Nikitin, I. G. Rudakova, P. N. Vlasov, S. G. Burd, A. V. Lebedeva, G. N. Avakyan
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 10, Iss 2, Pp 74-81 (2018)
At present, treatment recommendations are developed considering the principles of evidence-based medicine. General practitioners (GP) are offered a choice of different medications with the known characteristics of efficacy and tolerance. For a GP, th
Externí odkaz:
https://doaj.org/article/2dd1a25c4da044aab2272dbe49a4b792
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 9, Iss 3, Pp 32-38 (2017)
The incidence of epilepsy is highest in children and in elderly people (over 60 years of age). In about 75% of cases, the first seizures occur before the age of 16 with the maximal occurrence observed before the age of 10 [1]. The problems of diagnos
Externí odkaz:
https://doaj.org/article/a44ea05d382a470fa17d3ffce2f30199
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 9, Iss 1, Pp 79-85 (2017)
Pharmacotherapy of epilepsy requires deep knowledge of anti-epileptic drugs (AEDs), including the following issues: spectrum of therapeutic efficacy and therapeutic strength, adverse effects (especially severe and life-threatening adverse reactions);
Externí odkaz:
https://doaj.org/article/dcc3bf7b424540fba2488f6d40c7de8a